Fred Saad

2 articles listing Fred Saad in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial Nature Communications
2. Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer Nature Communications